Filters

542 Results

relevance


Curaleaf

Ad Alert

Curaleaf

FDA warning letter sparks changes to company’s marketing of CBD products.

Discover CBD

Ad Alert

Discover CBD

Unapproved drug treatment claims remain in wake of FDA warning letter.

Vicaine

Ad Alert

Vicaine

FDA warns marketer of illegal tianeptine supplement about unapproved drug treatment claims.

LASIK Providers Unclear on Risks

Ad Alert

LASIK Providers Unclear on Risks

The FDA sent warning letters to four LASIK providers for promoting the procedure on their websites without adequate warning about the risks involved.

That’s Natural

Ad Alert

That’s Natural

FDA reminds marijuana marketers that outing unproven treatment claims remains high on its list.

ZYTO Technologies

Ad Alert

ZYTO Technologies

FDA warning letter focuses on the ZYTO Hand Cradle, marketed as a medical diagnostic device.

Dr. Sherrill Sellman

Ad Alert

Dr. Sherrill Sellman

How a naturopathic doctor doubled down on her deceptive COVID-19 claims and attracted the attention of federal regulators.

Winter Tonic Plus

Ad Alert

Winter Tonic Plus

The seasons change but the FDA’s position on unapproved drug treatment claims does not.

Show More